Geron Corporation Strengthens Leadership Team to Accelerate Hematology-Oncology Growth

Geron Corporation Strengthens Leadership Team to Accelerate Hematology-Oncology Growth

Harout Semerjian, President and CEO at Geron Corporation, shared a post on LinkedIn:

“Welcome to our new leadership team members! Excited to collaborate with you and the entire Geron team as we move forward with our shared mission. Let’s make great things happen together.”

Quoting Geron Corporation’s post:

“This is a pivotal moment for Geron as we enhance our leadership team to deliver on our full potential.’ – Harout Semerjian, President & CEO

We’re proud to welcome four accomplished executives whose diverse expertise and leadership will help advance Geron’s strategic priorities to drive growth and impact:

  • Ahmed ElNawawi (Nawawi) – Chief Commercial Officer
  • Shanthakumar Tyavanagimatt (Shantha) – Chief Technical Officer
  • Dawn Schottlandt, CFA – Investor Relations and Corporate Affairs
  • Bryan Ridgell – Portfolio & Program Management, Chief of Staff

Collectively, they bring extensive U.S. and global hematology-oncology backgrounds and a proven track record of leading high-performing teams – further strengthening the organization shaping what’s next for Geron.

Please join us in welcoming them to Team Geron!”

Geron Corporation

You Can Also Read:

Harout Semerjian: A Visionary Leader Steering Geron Toward a New Era in Oncology

Geron Corporation Strengthens Leadership Team to Accelerate Hematology-Oncology Growth